Tango Therapeutics
Stock Forecast, Prediction & Price Target
Tango Therapeutics Financial Estimates
Tango Therapeutics Revenue Estimates
Tango Therapeutics EBITDA Estimates
Tango Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $37.04M N/A | $24.86M -32.88% | $36.52M 46.93% | Avg: $31.62M Low: $23.91M High: $55.18M avg. -13.42% | Avg: $31.79M Low: $22.93M High: $51.48M avg. 0.53% | Avg: $89.88M Low: $64.84M High: $145.57M avg. 182.73% | Avg: $105.75M Low: $76.29M High: $171.27M avg. 17.65% |
Net Income
% change YoY
| $-58.23M N/A | $-108.17M -85.75% | $-101.74M 5.94% | Avg: $-153.42M Low: $-157.93M High: $-93.62M avg. -50.79% | Avg: $-172.93M Low: $-164.55M High: $-97.40M avg. -12.71% | Avg: $-118.68M Low: $-214.29M High: $-75.71M avg. 31.36% | Avg: $-115.61M Low: $-208.74M High: $-73.75M avg. 2.58% |
EBITDA
% change YoY
| $-58.19M N/A | $-111.07M -90.87% | $-111.75M -0.61% | Avg: $-29.02M Low: $-50.65M High: $-21.94M avg. 74.03% | Avg: $-29.17M Low: $-47.25M High: $-21.05M avg. -0.53% | Avg: $-82.49M Low: $-133.61M High: $-59.51M avg. -182.73% | Avg: $-97.05M Low: $-157.20M High: $-70.02M avg. -17.65% |
EPS
% change YoY
| -$0.94 N/A | -$1.23 -30.85% | -$1.08 12.19% | Avg: -$1.31 Low: -$1.67 High: -$0.99 avg. -20.89% | Avg: -$1.43 Low: -$1.74 High: -$1.03 avg. -9.21% | Avg: -$1.26 Low: -$2.27 High: -$0.8 avg. 11.99% | Avg: -$1.22 Low: -$2.21 High: -$0.78 avg. 2.58% |
Operating Expenses
% change YoY
| $95.23M N/A | $135.93M 42.73% | $150.7M 10.86% | Avg: $26.87M Low: $20.32M High: $46.90M avg. -82.16% | Avg: $27.01M Low: $19.49M High: $43.75M avg. 0.53% | Avg: $76.38M Low: $55.10M High: $123.71M avg. 182.73% | Avg: $89.86M Low: $64.83M High: $145.55M avg. 17.65% |
FAQ
What is Tango Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -7.38% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -157.93M, average is -153.42M and high is -93.62M.
What is Tango Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 46.87% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $23.91M, average is $31.62M and high is $55.18M.
What is Tango Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -3.88% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$1.67, average is -$1.31 and high is $-0.99.
What is the best performing analyst?
In the last twelve months analysts have been covering Tango Therapeutics stock. The most successful analyst is Robert Burns.